VANIQA 11.5 %, cream tube, 30 g
Active ingredients: (RS)-eflornithine hydrochloride, (S)-eflornithine
Commercialized according to BDPMDispensing in France: Prescription only
Creamtube, 30 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VANIQA 11,5 pour cent, crème
- Pharmaceutical form
- crème
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) polyéthylène haute densité (PEHD) de 30 g
- Marketing authorisation holder
- ALMIRALL (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 18 Oct 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64328981CIP73567003CIP133400935670038Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ÉFLORNITHINEcrème | — | SA |
| ÉFLORNITHINEcrème | 115 mg · 1 g | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.